India · Delayed Price · Currency is INR Sandu Pharmaceuticals Statistics
Total Valuation
BOM:524703 has a market cap or net worth of INR 362.38 million. The enterprise value is 298.02 million.
| Market Cap | 362.38M |
| Enterprise Value | 298.02M |
Important Dates
The last earnings date was Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | Sep 4, 2026 |
Share Statistics
BOM:524703 has 9.66 million shares outstanding. The number of shares has decreased by -9.36% in one year.
| Current Share Class | 9.66M |
| Shares Outstanding | 9.66M |
| Shares Change (YoY) | -9.36% |
| Shares Change (QoQ) | -43.16% |
| Owned by Insiders (%) | 29.84% |
| Owned by Institutions (%) | 0.70% |
| Float | 4.61M |
Valuation Ratios
The trailing PE ratio is 18.57.
| PE Ratio | 18.57 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | 6.72 |
| P/OCF Ratio | 5.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 5.52.
| EV / Earnings | 16.83 |
| EV / Sales | 0.43 |
| EV / EBITDA | 9.67 |
| EV / EBIT | 12.69 |
| EV / FCF | 5.52 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.08 |
| Interest Coverage | 20.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.17% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.57% |
| Revenue Per Employee | 2.30M |
| Profits Per Employee | 58,449 |
| Employee Count | 303 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:524703 has paid 9.06 million in taxes.
| Income Tax | 9.06M |
| Effective Tax Rate | 33.85% |
Stock Price Statistics
The stock price has decreased by -22.45% in the last 52 weeks. The beta is 0.40, so BOM:524703's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -22.45% |
| 50-Day Moving Average | 40.54 |
| 200-Day Moving Average | 38.91 |
| Relative Strength Index (RSI) | 42.30 |
| Average Volume (20 Days) | 2,473 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524703 had revenue of INR 696.24 million and earned 17.71 million in profits. Earnings per share was 2.02.
| Revenue | 696.24M |
| Gross Profit | 403.46M |
| Operating Income | 23.49M |
| Pretax Income | 26.77M |
| Net Income | 17.71M |
| EBITDA | 30.83M |
| EBIT | 23.49M |
| Earnings Per Share (EPS) | 2.02 |
Balance Sheet
The company has 68.56 million in cash and 4.19 million in debt, with a net cash position of 64.37 million or 6.66 per share.
| Cash & Cash Equivalents | 68.56M |
| Total Debt | 4.19M |
| Net Cash | 64.37M |
| Net Cash Per Share | 6.66 |
| Equity (Book Value) | 436.73M |
| Book Value Per Share | 40.25 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 61.16 million and capital expenditures -7.20 million, giving a free cash flow of 53.96 million.
| Operating Cash Flow | 61.16M |
| Capital Expenditures | -7.20M |
| Depreciation & Amortization | 7.35M |
| Net Borrowing | -582,000 |
| Free Cash Flow | 53.96M |
| FCF Per Share | 5.59 |
Margins
Gross margin is 57.95%, with operating and profit margins of 3.37% and 2.54%.
| Gross Margin | 57.95% |
| Operating Margin | 3.37% |
| Pretax Margin | 3.85% |
| Profit Margin | 2.54% |
| EBITDA Margin | 4.43% |
| EBIT Margin | 3.37% |
| FCF Margin | 7.72% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.71%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.71% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.36% |
| Shareholder Yield | 12.07% |
| Earnings Yield | 4.89% |
| FCF Yield | 14.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |